Imipramine Hydrochloride
18 NDCs across 3 manufacturers|18 Generic,0 Brand
Imipramine Hydrochloride is used to treat attention deficit disorder with hyperactivity, depressive disorder, enuresis, pain and panic disorder, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Jan 1, 1982. FDA's Orange Book lists 14 AB-rated (therapeutically equivalent) products for this ingredient.
Imipramine Hydrochloride is available as 18 NDCs from 3 manufacturers (18 generic, 0 brand), with NADAC prices from $0.07 to $0.16 per EA — the most expensive product costs about 2.2× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
18
18G / 0B
Manufacturers
3
competing in market
Price Spread
$0.07 – $0.16
per EA
7d Activity
avg +1.7% WoW · of 18 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Oxford Pharmaceuticals, LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Tricyclic Antidepressant class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
3 manufacturers producing IMIPRAMINE HYDROCHLORIDE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
IMIPRAMINE HCL 50 MG TABLET | $0.1557 per EA | +1.33% |
IMIPRAMINE HCL 50 MG TABLET | $0.1557 per EA | +1.33% |
IMIPRAMINE HCL 50 MG TABLET | $0.1557 per EA | +1.33% |
IMIPRAMINE HCL 50 MG TABLET | $0.1557 per EA | +1.33% |
IMIPRAMINE HCL 50 MG TABLET | $0.1557 per EA | +1.33% |
IMIPRAMINE HCL 50 MG TABLET | $0.1557 per EA | +1.33% |
IMIPRAMINE HCL 25 MG TABLET | $0.0888 per EA | -2.64% |
IMIPRAMINE HCL 25 MG TABLET | $0.0888 per EA | -2.64% |
IMIPRAMINE HCL 25 MG TABLET | $0.0888 per EA | -2.64% |
IMIPRAMINE HCL 25 MG TABLET | $0.0888 per EA | -2.64% |
IMIPRAMINE HCL 25 MG TABLET | $0.0888 per EA | -2.64% |
IMIPRAMINE HCL 25 MG TABLET | $0.0888 per EA | -2.64% |
IMIPRAMINE HCL 10 MG TABLET | $0.0698 per EA | +6.32% |
IMIPRAMINE HCL 10 MG TABLET | $0.0698 per EA | +6.32% |
IMIPRAMINE HCL 10 MG TABLET | $0.0698 per EA | +6.32% |
IMIPRAMINE HCL 10 MG TABLET | $0.0698 per EA | +6.32% |
IMIPRAMINE HCL 10 MG TABLET | $0.0698 per EA | +6.32% |
IMIPRAMINE HCL 10 MG TABLET | $0.0698 per EA | +6.32% |
Frequently Asked Questions
What is Imipramine Hydrochloride used to treat?
Imipramine Hydrochloride is used to treat attention deficit disorder with hyperactivity, depressive disorder, enuresis, pain and panic disorder, per the National Library of Medicine's MED-RT classification.
When did Imipramine Hydrochloride become available as a generic?
FDA approved the first generic Imipramine Hydrochloride (ANDA) on Jan 1, 1982. The Orange Book currently lists 14 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How many Imipramine Hydrochloride products are on the market?
The Imipramine Hydrochloride drug market contains 18 NDCs from 3 manufacturers — 18 generic and 0 brand products.
What is the price range for Imipramine Hydrochloride?
NADAC reference prices for Imipramine Hydrochloride range from $0.0698 to $0.1557 per EA — the most expensive product costs about 2.2× the cheapest.
Which manufacturers make Imipramine Hydrochloride?
3 manufacturers list Imipramine Hydrochloride in NADAC. Ranked by number of NDCs, the largest are Oxford Pharmaceuticals, LLC (6), Leading Pharma, LLC (6), Strides Pharma Inc. (6).
How has the price of Imipramine Hydrochloride changed recently?
Over the past 7 days, 12 Imipramine Hydrochloride NDCs rose and 6 fell, with a market-wide average change of +1.7%.